Navigation Links
RedPrairie: Will they stay, or will they go?

br>
State Secretary of Commerce Mary Burke has placed a call to Jazwiec to discuss his concerns, but he was traveling this week and no formal meeting has been set. "We'll contact him to see what he says, and see if there's a way that we can be helpful," said Tony Hozeny, communications officer for the Department of Commerce. "Anytime someone says what he said, of course we're concerned."
......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/21/06


Page: 1 2 3 4

Related biology technology :

1. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
2. Federal bioenergy lab will give Wisconsin a chance to shine
3. Breaking down Wisconsins angel capital numbers
4. Innovation featured in NE Wisconsin Roundtable
5. Visions: Broderick says Wisconsin should be in top third in venture capital
6. Wisconsin building toward the major leagues of venture capital
7. Wisconsin Supreme Court to hear Menasha software case
8. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
9. Legislature should look to Wisconsins natural energy advantages
10. Stem cells get most attention, but they are only part of Wisconsins bio-portfolio
11. BIO 2007: Wisconsin makes its presence felt
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: RedPrairie Will they stay will they

(Date:5/28/2015)... MADISON, N.J. , May 28, 2015  Quest ... provider of diagnostic information services, announced that it is ... Conference in New York.  Steve Rusckowski , the ... goals and five point strategy.  The presentation is scheduled ... Time. The presentation will be webcast live ...
(Date:5/28/2015)... , May 27, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. An increasing ... biotechnology industries is anticipated. Nanotechnology will be ... - from formulations for optimal delivery to ...
(Date:5/28/2015)... 27, 2015 Research and Markets( http://www.researchandmarkets.com/research/6cg3zw/cell_therapy ... new report "Cell Therapy - Technologies, Markets ... This report describes and evaluates cell therapy technologies ... an important role in the practice of medicine. ... fashioned bone marrow transplants. Role of cells in ...
(Date:5/28/2015)... IN (PRWEB) May 28, 2015 The Academy ... National Model Aviation Day on August 15, 2015. National Model ... aviation nation-wide and to introduce model flying to the general ... 2,350 chartered clubs to participate in the celebration by hosting ... registered to host National Model Aviation Day events. View ...
Breaking Biology Technology:Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 3Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2Model flying pilots celebrate the Academy of Model Aeronautics Foundation’s Third Annual National Model Aviation Day 2
... , SAN DIEGO , INDIANAPOLIS and WALTHAM, Mass. ... AMLN ), Eli Lilly and Company (NYSE: LLY ) and ... and Drug Administration (FDA) has classified the BYDUREON™ (exenatide for extended-release injectable ... Prescription Drug User Fee Act (PDUFA) action date of October 22, ...
... , May 6 /PRNewswire-FirstCall/ - Aeterna Zentaris ... drug development company specialized in oncology and endocrinology, today ... and Drug Administration (FDA), orphan-drug designation for AEZS-108, its ... cancer. AEZS-108 is currently in a Phase 2 trial ...
... Belgium and LUND, Sweden , May 6, 2010 , ... - TB-402 Demonstrates Superior Antithrombotic ... ThromboGenics ... from,their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant,that is ...
Cached Biology Technology:BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 2BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 3BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 4BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 5BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 6BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 7BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 8Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer 2Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer 3ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402) 2ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402) 3ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402) 4ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402) 5ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402) 6ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402) 7
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... life forms that have been around since the dinosaurs, ... because they can simultaneously produce other valuable products ... Engineers at Oregon State University concede that such ... not science fiction many of the needed advances ...
... tested a new technique to ensure fresh produce is free ... particles created when gases are excited by an energy source. ... research shows, some can hide from its effects in the ... and vegetables is promoted as part of a healthy lifestyle, ...
... National Heart, Lung, and Blood Institute, part of the ... to Albert Einstein College of Medicine ... study of hemoglobin toxicity that may complicate blood transfusions ... goals include making blood transfusions safer and more effective ...
Cached Biology News:Ancient diatoms could make biofuels, electronics and health food -- at the same time 2Assessing a new technique for ensuring fresh produce remains Salmonella-free 2Einstein researcher receives $10.8 million grant to study toxic blood reactions caused by hemoglobin 2
...
... 48° Fixed Angle Polypropylene Rotor designed ... IEC Centra CL3/CL3R** and Centra-MP4/MP4R*. A ... operation. /MP4, ,EXCLUSIVE polypropylene rotor design ... be repeatedly autoclaved. Polypropylene rotors ...
... The Xcise is a powerful technology platform ... proteome analysis. High quality sample preparation ... user. , The Xcise is a powerful ... high throughput proteome analysis. It combines the ...
Request Info...
Biology Products: